300573 兴齐眼药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.02814.80714.61519.21414.069
总资产报酬率 ROA (%)1.67612.61112.20214.6809.678
投入资产回报率 ROIC (%)1.91614.35713.97317.46912.241

边际利润分析
销售毛利率 (%)76.10277.37378.74478.08773.133
营业利润率 (%)13.50518.84220.01124.16515.354
息税前利润/营业总收入 (%)11.56517.63218.05224.28915.796
净利润/营业总收入 (%)9.93216.35616.93720.34313.571

收益指标分析
经营活动净收益/利润总额(%)87.914101.219100.82097.623100.509
价值变动净收益/利润总额(%)0.0000.0000.0001.2910.000
营业外收支净额/利润总额(%)-13.432-4.350-7.010-1.994-3.117

偿债能力分析
流动比率 (X)3.1233.4805.6753.6891.385
速动比率 (X)2.6602.9574.8733.3431.063
资产负债率 (%)18.21716.49912.93620.2950.281
带息债务/全部投入资本 (%)2.2320.670-3.9782.8643.383
股东权益/带息债务 (%)4,201.20014,211.811-2,488.6923,211.5262,627.974
股东权益/负债合计 (%)448.942506.080673.062392.723251.135
利息保障倍数 (X)-33.878-41.567-27.88540.71117.420

营运能力分析
应收账款周转天数 (天)43.01136.97833.42538.58853.637
存货周转天数 (天)151.039140.014145.398128.372144.149